nodes	percent_of_prediction	percent_of_DWPC	metapath
Paroxetine—endogenous depression—Citalopram—alcohol dependence	0.125	0.376	CpDpCtD
Paroxetine—panic disorder—Citalopram—alcohol dependence	0.108	0.325	CpDpCtD
Paroxetine—bipolar disorder—Citalopram—alcohol dependence	0.0995	0.299	CpDpCtD
Paroxetine—CHRM2—alcohol dependence	0.0936	0.331	CbGaD
Paroxetine—SLC6A3—alcohol dependence	0.0815	0.288	CbGaD
Paroxetine—SLC6A4—alcohol dependence	0.0609	0.215	CbGaD
Paroxetine—HTR2A—alcohol dependence	0.0468	0.166	CbGaD
Paroxetine—SLC6A3—Citalopram—alcohol dependence	0.0437	0.206	CbGbCtD
Paroxetine—SLC6A4—Citalopram—alcohol dependence	0.0382	0.18	CbGbCtD
Paroxetine—SLC6A2—Citalopram—alcohol dependence	0.032	0.151	CbGbCtD
Paroxetine—CHRM1—Citalopram—alcohol dependence	0.0285	0.134	CbGbCtD
Paroxetine—CYP2B6—Citalopram—alcohol dependence	0.0198	0.0936	CbGbCtD
Paroxetine—ABCB1—Naltrexone—alcohol dependence	0.0154	0.0724	CbGbCtD
Paroxetine—CYP2C9—Disulfiram—alcohol dependence	0.0147	0.0694	CbGbCtD
Paroxetine—ABCB1—Citalopram—alcohol dependence	0.0102	0.048	CbGbCtD
Paroxetine—CYP2D6—Citalopram—alcohol dependence	0.00959	0.0452	CbGbCtD
Paroxetine—SLC6A2—locus ceruleus—alcohol dependence	0.00182	0.0688	CbGeAlD
Paroxetine—TACR1—nerve—alcohol dependence	0.00134	0.0507	CbGeAlD
Paroxetine—HTR2A—locus ceruleus—alcohol dependence	0.00109	0.0413	CbGeAlD
Paroxetine—SLC6A2—autonomic nervous system—alcohol dependence	0.000966	0.0366	CbGeAlD
Paroxetine—HTR2A—cerebellar cortex—alcohol dependence	0.00089	0.0337	CbGeAlD
Paroxetine—SLC6A3—nerve—alcohol dependence	0.000673	0.0255	CbGeAlD
Paroxetine—HTR2A—pons—alcohol dependence	0.000629	0.0238	CbGeAlD
Paroxetine—HTR2A—autonomic nervous system—alcohol dependence	0.00058	0.022	CbGeAlD
Paroxetine—TACR1—brainstem—alcohol dependence	0.000575	0.0218	CbGeAlD
Paroxetine—TACR1—forebrain—alcohol dependence	0.000555	0.021	CbGeAlD
Paroxetine—SLC6A2—nerve—alcohol dependence	0.000543	0.0206	CbGeAlD
Paroxetine—TACR1—digestive system—alcohol dependence	0.000389	0.0147	CbGeAlD
Paroxetine—TACR1—blood—alcohol dependence	0.000371	0.014	CbGeAlD
Paroxetine—HTR2A—nerve—alcohol dependence	0.000326	0.0124	CbGeAlD
Paroxetine—TACR1—endocrine gland—alcohol dependence	0.000322	0.0122	CbGeAlD
Paroxetine—TACR1—testis—alcohol dependence	0.000307	0.0116	CbGeAlD
Paroxetine—TACR1—nervous system—alcohol dependence	0.000301	0.0114	CbGeAlD
Paroxetine—TACR1—central nervous system—alcohol dependence	0.00029	0.011	CbGeAlD
Paroxetine—SLC6A3—brainstem—alcohol dependence	0.000289	0.0109	CbGeAlD
Paroxetine—CHRM4—testis—alcohol dependence	0.000288	0.0109	CbGeAlD
Paroxetine—CHRM4—nervous system—alcohol dependence	0.000283	0.0107	CbGeAlD
Paroxetine—CHRM2—forebrain—alcohol dependence	0.00028	0.0106	CbGeAlD
Paroxetine—SLC6A3—forebrain—alcohol dependence	0.000279	0.0106	CbGeAlD
Paroxetine—CHRM4—central nervous system—alcohol dependence	0.000272	0.0103	CbGeAlD
Paroxetine—SLC6A4—brainstem—alcohol dependence	0.000265	0.01	CbGeAlD
Paroxetine—SLC6A4—forebrain—alcohol dependence	0.000256	0.00968	CbGeAlD
Paroxetine—CHRM1—forebrain—alcohol dependence	0.000255	0.00964	CbGeAlD
Paroxetine—CHRM2—cardiovascular system—alcohol dependence	0.000237	0.00895	CbGeAlD
Paroxetine—SLC6A2—brainstem—alcohol dependence	0.000233	0.00883	CbGeAlD
Paroxetine—TACR1—brain—alcohol dependence	0.00023	0.00871	CbGeAlD
Paroxetine—CHRM3—forebrain—alcohol dependence	0.000228	0.00863	CbGeAlD
Paroxetine—SLC6A2—forebrain—alcohol dependence	0.000225	0.00852	CbGeAlD
Paroxetine—CHRM5—nervous system—alcohol dependence	0.000221	0.00837	CbGeAlD
Paroxetine—CHRM4—brain—alcohol dependence	0.000216	0.00819	CbGeAlD
Paroxetine—CHRM1—cardiovascular system—alcohol dependence	0.000215	0.00815	CbGeAlD
Paroxetine—CHRM5—central nervous system—alcohol dependence	0.000213	0.00806	CbGeAlD
Paroxetine—SLC6A3—midbrain—alcohol dependence	0.000184	0.00697	CbGeAlD
Paroxetine—SLC6A4—digestive system—alcohol dependence	0.000179	0.00679	CbGeAlD
Paroxetine—SLC6A2—gonad—alcohol dependence	0.000173	0.00654	CbGeAlD
Paroxetine—SLC6A4—blood—alcohol dependence	0.000171	0.00647	CbGeAlD
Paroxetine—CHRM5—brain—alcohol dependence	0.000169	0.0064	CbGeAlD
Paroxetine—SLC6A4—midbrain—alcohol dependence	0.000169	0.00639	CbGeAlD
Paroxetine—CHRM2—endocrine gland—alcohol dependence	0.000162	0.00614	CbGeAlD
Paroxetine—CHRM3—digestive system—alcohol dependence	0.00016	0.00605	CbGeAlD
Paroxetine—SLC6A3—testis—alcohol dependence	0.000154	0.00584	CbGeAlD
Paroxetine—CYP2B6—adrenal cortex—alcohol dependence	0.000154	0.00582	CbGeAlD
Paroxetine—CHRM2—nervous system—alcohol dependence	0.000152	0.00575	CbGeAlD
Paroxetine—SLC6A3—nervous system—alcohol dependence	0.000151	0.00573	CbGeAlD
Paroxetine—SLC6A4—endocrine gland—alcohol dependence	0.000148	0.00561	CbGeAlD
Paroxetine—CHRM1—endocrine gland—alcohol dependence	0.000148	0.00559	CbGeAlD
Paroxetine—CHRM2—central nervous system—alcohol dependence	0.000146	0.00553	CbGeAlD
Paroxetine—SLC6A3—central nervous system—alcohol dependence	0.000146	0.00552	CbGeAlD
Paroxetine—SLC6A3—cerebellum—alcohol dependence	0.000142	0.00539	CbGeAlD
Paroxetine—CYP2B6—cardiovascular system—alcohol dependence	0.00014	0.00531	CbGeAlD
Paroxetine—HTR2A—brainstem—alcohol dependence	0.00014	0.00531	CbGeAlD
Paroxetine—CYP2C9—cardiovascular system—alcohol dependence	0.000139	0.00526	CbGeAlD
Paroxetine—SLC6A4—nervous system—alcohol dependence	0.000139	0.00525	CbGeAlD
Paroxetine—CHRM1—nervous system—alcohol dependence	0.000138	0.00523	CbGeAlD
Paroxetine—HTR2A—forebrain—alcohol dependence	0.000135	0.00512	CbGeAlD
Paroxetine—SLC6A4—central nervous system—alcohol dependence	0.000134	0.00506	CbGeAlD
Paroxetine—CHRM1—central nervous system—alcohol dependence	0.000133	0.00504	CbGeAlD
Paroxetine—CHRM3—endocrine gland—alcohol dependence	0.000132	0.005	CbGeAlD
Paroxetine—SLC6A2—endocrine gland—alcohol dependence	0.000131	0.00494	CbGeAlD
Paroxetine—CYP2D6—brainstem—alcohol dependence	0.000128	0.00483	CbGeAlD
Paroxetine—CYP2B6—gonad—alcohol dependence	0.000127	0.00482	CbGeAlD
Paroxetine—CHRM3—testis—alcohol dependence	0.000126	0.00477	CbGeAlD
Paroxetine—SLC6A2—testis—alcohol dependence	0.000124	0.00471	CbGeAlD
Paroxetine—CHRM3—nervous system—alcohol dependence	0.000124	0.00468	CbGeAlD
Paroxetine—CYP2C8—blood—alcohol dependence	0.000124	0.00468	CbGeAlD
Paroxetine—CYP2D6—forebrain—alcohol dependence	0.000123	0.00466	CbGeAlD
Paroxetine—SLC6A2—nervous system—alcohol dependence	0.000122	0.00462	CbGeAlD
Paroxetine—CHRM3—central nervous system—alcohol dependence	0.000119	0.00451	CbGeAlD
Paroxetine—SLC6A2—central nervous system—alcohol dependence	0.000118	0.00445	CbGeAlD
Paroxetine—CYP2B6—digestive system—alcohol dependence	0.000116	0.00441	CbGeAlD
Paroxetine—CHRM2—brain—alcohol dependence	0.000116	0.00439	CbGeAlD
Paroxetine—SLC6A3—brain—alcohol dependence	0.000116	0.00438	CbGeAlD
Paroxetine—CYP2C9—digestive system—alcohol dependence	0.000115	0.00436	CbGeAlD
Paroxetine—HTR2A—cardiovascular system—alcohol dependence	0.000114	0.00433	CbGeAlD
Paroxetine—CYP2B6—blood—alcohol dependence	0.000111	0.0042	CbGeAlD
Paroxetine—CYP2C9—blood—alcohol dependence	0.00011	0.00416	CbGeAlD
Paroxetine—CYP2C8—endocrine gland—alcohol dependence	0.000107	0.00406	CbGeAlD
Paroxetine—SLC6A4—brain—alcohol dependence	0.000106	0.00401	CbGeAlD
Paroxetine—CHRM1—brain—alcohol dependence	0.000106	0.004	CbGeAlD
Paroxetine—HTR2A—gonad—alcohol dependence	0.000104	0.00393	CbGeAlD
Paroxetine—CYP2C8—testis—alcohol dependence	0.000102	0.00387	CbGeAlD
Paroxetine—CYP2C8—liver—alcohol dependence	9.67e-05	0.00366	CbGeAlD
Paroxetine—CYP2B6—endocrine gland—alcohol dependence	9.62e-05	0.00364	CbGeAlD
Paroxetine—CYP2C9—endocrine gland—alcohol dependence	9.52e-05	0.00361	CbGeAlD
Paroxetine—HTR2A—digestive system—alcohol dependence	9.49e-05	0.00359	CbGeAlD
Paroxetine—CHRM3—brain—alcohol dependence	9.45e-05	0.00358	CbGeAlD
Paroxetine—SLC6A2—brain—alcohol dependence	9.34e-05	0.00353	CbGeAlD
Paroxetine—CYP2B6—testis—alcohol dependence	9.17e-05	0.00347	CbGeAlD
Paroxetine—HTR2A—blood—alcohol dependence	9.04e-05	0.00342	CbGeAlD
Paroxetine—CYP2B6—nervous system—alcohol dependence	9e-05	0.00341	CbGeAlD
Paroxetine—HTR2A—midbrain—alcohol dependence	8.93e-05	0.00338	CbGeAlD
Paroxetine—ABCB1—forebrain—alcohol dependence	8.86e-05	0.00336	CbGeAlD
Paroxetine—CYP2B6—liver—alcohol dependence	8.67e-05	0.00328	CbGeAlD
Paroxetine—CYP2B6—central nervous system—alcohol dependence	8.67e-05	0.00328	CbGeAlD
Paroxetine—CYP2D6—digestive system—alcohol dependence	8.65e-05	0.00327	CbGeAlD
Paroxetine—CYP2C9—liver—alcohol dependence	8.59e-05	0.00325	CbGeAlD
Paroxetine—CYP2D6—blood—alcohol dependence	8.24e-05	0.00312	CbGeAlD
Paroxetine—ABCB1—adrenal cortex—alcohol dependence	8.21e-05	0.00311	CbGeAlD
Paroxetine—HTR2A—endocrine gland—alcohol dependence	7.84e-05	0.00297	CbGeAlD
Paroxetine—CYP2C8—brain—alcohol dependence	7.67e-05	0.0029	CbGeAlD
Paroxetine—ABCB1—cardiovascular system—alcohol dependence	7.49e-05	0.00284	CbGeAlD
Paroxetine—HTR2A—testis—alcohol dependence	7.48e-05	0.00283	CbGeAlD
Paroxetine—HTR2A—nervous system—alcohol dependence	7.34e-05	0.00278	CbGeAlD
Paroxetine—ABCB1—pancreas—alcohol dependence	7.28e-05	0.00276	CbGeAlD
Paroxetine—CYP2D6—endocrine gland—alcohol dependence	7.15e-05	0.00271	CbGeAlD
Paroxetine—HTR2A—liver—alcohol dependence	7.07e-05	0.00268	CbGeAlD
Paroxetine—HTR2A—central nervous system—alcohol dependence	7.07e-05	0.00268	CbGeAlD
Paroxetine—HTR2A—cerebellum—alcohol dependence	6.91e-05	0.00262	CbGeAlD
Paroxetine—CYP2B6—brain—alcohol dependence	6.88e-05	0.0026	CbGeAlD
Paroxetine—CYP2D6—testis—alcohol dependence	6.81e-05	0.00258	CbGeAlD
Paroxetine—ABCB1—gonad—alcohol dependence	6.8e-05	0.00257	CbGeAlD
Paroxetine—CYP2D6—nervous system—alcohol dependence	6.69e-05	0.00253	CbGeAlD
Paroxetine—CYP2D6—liver—alcohol dependence	6.44e-05	0.00244	CbGeAlD
Paroxetine—CYP2D6—central nervous system—alcohol dependence	6.44e-05	0.00244	CbGeAlD
Paroxetine—CYP2D6—cerebellum—alcohol dependence	6.29e-05	0.00238	CbGeAlD
Paroxetine—ABCB1—digestive system—alcohol dependence	6.22e-05	0.00236	CbGeAlD
Paroxetine—ABCB1—blood—alcohol dependence	5.93e-05	0.00224	CbGeAlD
Paroxetine—ABCB1—midbrain—alcohol dependence	5.85e-05	0.00222	CbGeAlD
Paroxetine—HTR2A—brain—alcohol dependence	5.61e-05	0.00212	CbGeAlD
Paroxetine—Tremor—Acamprosate—alcohol dependence	5.53e-05	0.000564	CcSEcCtD
Paroxetine—Ataxia—Citalopram—alcohol dependence	5.52e-05	0.000564	CcSEcCtD
Paroxetine—Flatulence—Naltrexone—alcohol dependence	5.5e-05	0.000562	CcSEcCtD
Paroxetine—Tension—Naltrexone—alcohol dependence	5.48e-05	0.000559	CcSEcCtD
Paroxetine—Ill-defined disorder—Acamprosate—alcohol dependence	5.47e-05	0.000559	CcSEcCtD
Paroxetine—Dysgeusia—Naltrexone—alcohol dependence	5.46e-05	0.000558	CcSEcCtD
Paroxetine—Dehydration—Citalopram—alcohol dependence	5.46e-05	0.000558	CcSEcCtD
Paroxetine—Anaemia—Acamprosate—alcohol dependence	5.45e-05	0.000557	CcSEcCtD
Paroxetine—Liver function test abnormal—Citalopram—alcohol dependence	5.42e-05	0.000554	CcSEcCtD
Paroxetine—Agitation—Acamprosate—alcohol dependence	5.42e-05	0.000554	CcSEcCtD
Paroxetine—Nervousness—Naltrexone—alcohol dependence	5.42e-05	0.000554	CcSEcCtD
Paroxetine—Back pain—Naltrexone—alcohol dependence	5.4e-05	0.000551	CcSEcCtD
Paroxetine—Angioedema—Acamprosate—alcohol dependence	5.39e-05	0.00055	CcSEcCtD
Paroxetine—Dry skin—Citalopram—alcohol dependence	5.38e-05	0.00055	CcSEcCtD
Paroxetine—Muscle spasms—Naltrexone—alcohol dependence	5.36e-05	0.000548	CcSEcCtD
Paroxetine—Orthostatic hypotension—Citalopram—alcohol dependence	5.36e-05	0.000548	CcSEcCtD
Paroxetine—Hypokalaemia—Citalopram—alcohol dependence	5.34e-05	0.000546	CcSEcCtD
Paroxetine—Malaise—Acamprosate—alcohol dependence	5.32e-05	0.000543	CcSEcCtD
Paroxetine—Breast disorder—Citalopram—alcohol dependence	5.3e-05	0.000542	CcSEcCtD
Paroxetine—Vertigo—Acamprosate—alcohol dependence	5.3e-05	0.000541	CcSEcCtD
Paroxetine—Syncope—Acamprosate—alcohol dependence	5.29e-05	0.00054	CcSEcCtD
Paroxetine—Toxic epidermal necrolysis—Citalopram—alcohol dependence	5.29e-05	0.00054	CcSEcCtD
Paroxetine—Cramp muscle—Citalopram—alcohol dependence	5.29e-05	0.00054	CcSEcCtD
Paroxetine—Aspartate aminotransferase increased—Citalopram—alcohol dependence	5.29e-05	0.00054	CcSEcCtD
Paroxetine—Leukopenia—Acamprosate—alcohol dependence	5.28e-05	0.000539	CcSEcCtD
Paroxetine—Vision blurred—Naltrexone—alcohol dependence	5.26e-05	0.000537	CcSEcCtD
Paroxetine—Nasopharyngitis—Citalopram—alcohol dependence	5.25e-05	0.000536	CcSEcCtD
Paroxetine—Tremor—Naltrexone—alcohol dependence	5.23e-05	0.000534	CcSEcCtD
Paroxetine—Palpitations—Acamprosate—alcohol dependence	5.21e-05	0.000532	CcSEcCtD
Paroxetine—Gastritis—Citalopram—alcohol dependence	5.2e-05	0.000531	CcSEcCtD
Paroxetine—Loss of consciousness—Acamprosate—alcohol dependence	5.18e-05	0.000529	CcSEcCtD
Paroxetine—Muscular weakness—Citalopram—alcohol dependence	5.18e-05	0.000529	CcSEcCtD
Paroxetine—Alanine aminotransferase increased—Citalopram—alcohol dependence	5.18e-05	0.000529	CcSEcCtD
Paroxetine—Ill-defined disorder—Naltrexone—alcohol dependence	5.18e-05	0.000529	CcSEcCtD
Paroxetine—Cough—Acamprosate—alcohol dependence	5.15e-05	0.000526	CcSEcCtD
Paroxetine—ABCB1—endocrine gland—alcohol dependence	5.14e-05	0.00195	CbGeAlD
Paroxetine—Agitation—Naltrexone—alcohol dependence	5.13e-05	0.000524	CcSEcCtD
Paroxetine—CYP2D6—brain—alcohol dependence	5.11e-05	0.00194	CbGeAlD
Paroxetine—Convulsion—Acamprosate—alcohol dependence	5.11e-05	0.000522	CcSEcCtD
Paroxetine—Angioedema—Naltrexone—alcohol dependence	5.1e-05	0.000521	CcSEcCtD
Paroxetine—Hypertension—Acamprosate—alcohol dependence	5.09e-05	0.00052	CcSEcCtD
Paroxetine—Asthma—Citalopram—alcohol dependence	5.07e-05	0.000518	CcSEcCtD
Paroxetine—Influenza—Citalopram—alcohol dependence	5.07e-05	0.000518	CcSEcCtD
Paroxetine—Dysphagia—Citalopram—alcohol dependence	5.07e-05	0.000518	CcSEcCtD
Paroxetine—Malaise—Naltrexone—alcohol dependence	5.03e-05	0.000514	CcSEcCtD
Paroxetine—Eosinophilia—Citalopram—alcohol dependence	5.02e-05	0.000513	CcSEcCtD
Paroxetine—Chest pain—Acamprosate—alcohol dependence	5.02e-05	0.000513	CcSEcCtD
Paroxetine—Arthralgia—Acamprosate—alcohol dependence	5.02e-05	0.000513	CcSEcCtD
Paroxetine—Myalgia—Acamprosate—alcohol dependence	5.02e-05	0.000513	CcSEcCtD
Paroxetine—Syncope—Naltrexone—alcohol dependence	5e-05	0.000511	CcSEcCtD
Paroxetine—Anxiety—Acamprosate—alcohol dependence	5e-05	0.000511	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	4.99e-05	0.000509	CcSEcCtD
Paroxetine—Pancreatitis—Citalopram—alcohol dependence	4.97e-05	0.000508	CcSEcCtD
Paroxetine—Discomfort—Acamprosate—alcohol dependence	4.96e-05	0.000507	CcSEcCtD
Paroxetine—Sweating increased—Citalopram—alcohol dependence	4.94e-05	0.000505	CcSEcCtD
Paroxetine—Angina pectoris—Citalopram—alcohol dependence	4.94e-05	0.000505	CcSEcCtD
Paroxetine—Palpitations—Naltrexone—alcohol dependence	4.93e-05	0.000504	CcSEcCtD
Paroxetine—Dry mouth—Acamprosate—alcohol dependence	4.91e-05	0.000502	CcSEcCtD
Paroxetine—Loss of consciousness—Naltrexone—alcohol dependence	4.9e-05	0.000501	CcSEcCtD
Paroxetine—ABCB1—testis—alcohol dependence	4.9e-05	0.00186	CbGeAlD
Paroxetine—Bronchitis—Citalopram—alcohol dependence	4.88e-05	0.000498	CcSEcCtD
Paroxetine—Cough—Naltrexone—alcohol dependence	4.87e-05	0.000497	CcSEcCtD
Paroxetine—Confusional state—Acamprosate—alcohol dependence	4.85e-05	0.000496	CcSEcCtD
Paroxetine—Convulsion—Naltrexone—alcohol dependence	4.83e-05	0.000494	CcSEcCtD
Paroxetine—Pancytopenia—Citalopram—alcohol dependence	4.82e-05	0.000492	CcSEcCtD
Paroxetine—Hypertension—Naltrexone—alcohol dependence	4.82e-05	0.000492	CcSEcCtD
Paroxetine—Anaphylactic shock—Acamprosate—alcohol dependence	4.81e-05	0.000492	CcSEcCtD
Paroxetine—ABCB1—nervous system—alcohol dependence	4.81e-05	0.00182	CbGeAlD
Paroxetine—Infection—Acamprosate—alcohol dependence	4.78e-05	0.000488	CcSEcCtD
Paroxetine—Myalgia—Naltrexone—alcohol dependence	4.75e-05	0.000485	CcSEcCtD
Paroxetine—Chest pain—Naltrexone—alcohol dependence	4.75e-05	0.000485	CcSEcCtD
Paroxetine—Arthralgia—Naltrexone—alcohol dependence	4.75e-05	0.000485	CcSEcCtD
Paroxetine—Dysuria—Citalopram—alcohol dependence	4.74e-05	0.000485	CcSEcCtD
Paroxetine—Shock—Acamprosate—alcohol dependence	4.74e-05	0.000484	CcSEcCtD
Paroxetine—Anxiety—Naltrexone—alcohol dependence	4.73e-05	0.000484	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	4.72e-05	0.000482	CcSEcCtD
Paroxetine—Thrombocytopenia—Acamprosate—alcohol dependence	4.71e-05	0.000481	CcSEcCtD
Paroxetine—Tachycardia—Acamprosate—alcohol dependence	4.7e-05	0.00048	CcSEcCtD
Paroxetine—Discomfort—Naltrexone—alcohol dependence	4.69e-05	0.000479	CcSEcCtD
Paroxetine—Pollakiuria—Citalopram—alcohol dependence	4.69e-05	0.000479	CcSEcCtD
Paroxetine—Skin disorder—Acamprosate—alcohol dependence	4.67e-05	0.000478	CcSEcCtD
Paroxetine—Erectile dysfunction—Citalopram—alcohol dependence	4.67e-05	0.000477	CcSEcCtD
Paroxetine—Hyperhidrosis—Acamprosate—alcohol dependence	4.65e-05	0.000475	CcSEcCtD
Paroxetine—Dry mouth—Naltrexone—alcohol dependence	4.65e-05	0.000475	CcSEcCtD
Paroxetine—ABCB1—liver—alcohol dependence	4.63e-05	0.00175	CbGeAlD
Paroxetine—ABCB1—central nervous system—alcohol dependence	4.63e-05	0.00175	CbGeAlD
Paroxetine—Photosensitivity reaction—Citalopram—alcohol dependence	4.63e-05	0.000473	CcSEcCtD
Paroxetine—Weight increased—Citalopram—alcohol dependence	4.62e-05	0.000472	CcSEcCtD
Paroxetine—Confusional state—Naltrexone—alcohol dependence	4.59e-05	0.000469	CcSEcCtD
Paroxetine—Weight decreased—Citalopram—alcohol dependence	4.59e-05	0.000469	CcSEcCtD
Paroxetine—Hyperglycaemia—Citalopram—alcohol dependence	4.58e-05	0.000468	CcSEcCtD
Paroxetine—Oedema—Naltrexone—alcohol dependence	4.55e-05	0.000465	CcSEcCtD
Paroxetine—Anaphylactic shock—Naltrexone—alcohol dependence	4.55e-05	0.000465	CcSEcCtD
Paroxetine—Pneumonia—Citalopram—alcohol dependence	4.55e-05	0.000465	CcSEcCtD
Paroxetine—ABCB1—cerebellum—alcohol dependence	4.53e-05	0.00171	CbGeAlD
Paroxetine—Infection—Naltrexone—alcohol dependence	4.52e-05	0.000462	CcSEcCtD
Paroxetine—Depression—Citalopram—alcohol dependence	4.51e-05	0.000461	CcSEcCtD
Paroxetine—Hypotension—Acamprosate—alcohol dependence	4.5e-05	0.000459	CcSEcCtD
Paroxetine—Stevens-Johnson syndrome—Citalopram—alcohol dependence	4.49e-05	0.000458	CcSEcCtD
Paroxetine—Shock—Naltrexone—alcohol dependence	4.48e-05	0.000458	CcSEcCtD
Paroxetine—Nervous system disorder—Naltrexone—alcohol dependence	4.47e-05	0.000456	CcSEcCtD
Paroxetine—Acute coronary syndrome—Citalopram—alcohol dependence	4.46e-05	0.000456	CcSEcCtD
Paroxetine—Tachycardia—Naltrexone—alcohol dependence	4.44e-05	0.000454	CcSEcCtD
Paroxetine—Neuropathy peripheral—Citalopram—alcohol dependence	4.43e-05	0.000453	CcSEcCtD
Paroxetine—Myocardial infarction—Citalopram—alcohol dependence	4.43e-05	0.000453	CcSEcCtD
Paroxetine—Skin disorder—Naltrexone—alcohol dependence	4.42e-05	0.000452	CcSEcCtD
Paroxetine—Jaundice—Citalopram—alcohol dependence	4.41e-05	0.00045	CcSEcCtD
Paroxetine—Stomatitis—Citalopram—alcohol dependence	4.41e-05	0.00045	CcSEcCtD
Paroxetine—Hyperhidrosis—Naltrexone—alcohol dependence	4.4e-05	0.00045	CcSEcCtD
Paroxetine—Conjunctivitis—Citalopram—alcohol dependence	4.4e-05	0.000449	CcSEcCtD
Paroxetine—Urinary tract infection—Citalopram—alcohol dependence	4.4e-05	0.000449	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Acamprosate—alcohol dependence	4.38e-05	0.000448	CcSEcCtD
Paroxetine—Insomnia—Acamprosate—alcohol dependence	4.35e-05	0.000445	CcSEcCtD
Paroxetine—Sweating—Citalopram—alcohol dependence	4.34e-05	0.000443	CcSEcCtD
Paroxetine—Paraesthesia—Acamprosate—alcohol dependence	4.32e-05	0.000441	CcSEcCtD
Paroxetine—Haematuria—Citalopram—alcohol dependence	4.31e-05	0.000441	CcSEcCtD
Paroxetine—Dyspnoea—Acamprosate—alcohol dependence	4.29e-05	0.000438	CcSEcCtD
Paroxetine—Somnolence—Acamprosate—alcohol dependence	4.28e-05	0.000437	CcSEcCtD
Paroxetine—Hepatobiliary disease—Citalopram—alcohol dependence	4.28e-05	0.000437	CcSEcCtD
Paroxetine—Epistaxis—Citalopram—alcohol dependence	4.27e-05	0.000436	CcSEcCtD
Paroxetine—Sinusitis—Citalopram—alcohol dependence	4.24e-05	0.000434	CcSEcCtD
Paroxetine—Dyspepsia—Acamprosate—alcohol dependence	4.24e-05	0.000433	CcSEcCtD
Paroxetine—Agranulocytosis—Citalopram—alcohol dependence	4.22e-05	0.000431	CcSEcCtD
Paroxetine—Decreased appetite—Acamprosate—alcohol dependence	4.18e-05	0.000427	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Acamprosate—alcohol dependence	4.16e-05	0.000424	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Naltrexone—alcohol dependence	4.15e-05	0.000424	CcSEcCtD
Paroxetine—Bradycardia—Citalopram—alcohol dependence	4.13e-05	0.000422	CcSEcCtD
Paroxetine—Insomnia—Naltrexone—alcohol dependence	4.12e-05	0.000421	CcSEcCtD
Paroxetine—Pain—Acamprosate—alcohol dependence	4.12e-05	0.00042	CcSEcCtD
Paroxetine—Constipation—Acamprosate—alcohol dependence	4.12e-05	0.00042	CcSEcCtD
Paroxetine—Paraesthesia—Naltrexone—alcohol dependence	4.09e-05	0.000418	CcSEcCtD
Paroxetine—Haemoglobin—Citalopram—alcohol dependence	4.08e-05	0.000417	CcSEcCtD
Paroxetine—Rhinitis—Citalopram—alcohol dependence	4.07e-05	0.000416	CcSEcCtD
Paroxetine—Haemorrhage—Citalopram—alcohol dependence	4.06e-05	0.000415	CcSEcCtD
Paroxetine—Hepatitis—Citalopram—alcohol dependence	4.06e-05	0.000415	CcSEcCtD
Paroxetine—Dyspnoea—Naltrexone—alcohol dependence	4.06e-05	0.000415	CcSEcCtD
Paroxetine—Somnolence—Naltrexone—alcohol dependence	4.05e-05	0.000414	CcSEcCtD
Paroxetine—Hypoaesthesia—Citalopram—alcohol dependence	4.04e-05	0.000413	CcSEcCtD
Paroxetine—Hallucination—Citalopram—alcohol dependence	4.04e-05	0.000413	CcSEcCtD
Paroxetine—Pharyngitis—Citalopram—alcohol dependence	4.03e-05	0.000412	CcSEcCtD
Paroxetine—Oedema peripheral—Citalopram—alcohol dependence	4e-05	0.000409	CcSEcCtD
Paroxetine—Connective tissue disorder—Citalopram—alcohol dependence	3.99e-05	0.000408	CcSEcCtD
Paroxetine—Feeling abnormal—Acamprosate—alcohol dependence	3.97e-05	0.000405	CcSEcCtD
Paroxetine—Decreased appetite—Naltrexone—alcohol dependence	3.96e-05	0.000404	CcSEcCtD
Paroxetine—Gastrointestinal pain—Acamprosate—alcohol dependence	3.94e-05	0.000402	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Naltrexone—alcohol dependence	3.93e-05	0.000402	CcSEcCtD
Paroxetine—Fatigue—Naltrexone—alcohol dependence	3.93e-05	0.000401	CcSEcCtD
Paroxetine—Visual impairment—Citalopram—alcohol dependence	3.91e-05	0.0004	CcSEcCtD
Paroxetine—Pain—Naltrexone—alcohol dependence	3.89e-05	0.000398	CcSEcCtD
Paroxetine—Constipation—Naltrexone—alcohol dependence	3.89e-05	0.000398	CcSEcCtD
Paroxetine—Erythema multiforme—Citalopram—alcohol dependence	3.84e-05	0.000392	CcSEcCtD
Paroxetine—Urticaria—Acamprosate—alcohol dependence	3.82e-05	0.000391	CcSEcCtD
Paroxetine—Body temperature increased—Acamprosate—alcohol dependence	3.8e-05	0.000389	CcSEcCtD
Paroxetine—Abdominal pain—Acamprosate—alcohol dependence	3.8e-05	0.000389	CcSEcCtD
Paroxetine—Eye disorder—Citalopram—alcohol dependence	3.8e-05	0.000388	CcSEcCtD
Paroxetine—Tinnitus—Citalopram—alcohol dependence	3.79e-05	0.000387	CcSEcCtD
Paroxetine—Flushing—Citalopram—alcohol dependence	3.77e-05	0.000385	CcSEcCtD
Paroxetine—Cardiac disorder—Citalopram—alcohol dependence	3.77e-05	0.000385	CcSEcCtD
Paroxetine—Feeling abnormal—Naltrexone—alcohol dependence	3.75e-05	0.000383	CcSEcCtD
Paroxetine—Gastrointestinal pain—Naltrexone—alcohol dependence	3.72e-05	0.00038	CcSEcCtD
Paroxetine—Angiopathy—Citalopram—alcohol dependence	3.68e-05	0.000376	CcSEcCtD
Paroxetine—ABCB1—brain—alcohol dependence	3.68e-05	0.00139	CbGeAlD
Paroxetine—Immune system disorder—Citalopram—alcohol dependence	3.67e-05	0.000375	CcSEcCtD
Paroxetine—Mediastinal disorder—Citalopram—alcohol dependence	3.66e-05	0.000374	CcSEcCtD
Paroxetine—Chills—Citalopram—alcohol dependence	3.64e-05	0.000372	CcSEcCtD
Paroxetine—Arrhythmia—Citalopram—alcohol dependence	3.63e-05	0.000371	CcSEcCtD
Paroxetine—Urticaria—Naltrexone—alcohol dependence	3.62e-05	0.00037	CcSEcCtD
Paroxetine—Abdominal pain—Naltrexone—alcohol dependence	3.6e-05	0.000368	CcSEcCtD
Paroxetine—Body temperature increased—Naltrexone—alcohol dependence	3.6e-05	0.000368	CcSEcCtD
Paroxetine—Alopecia—Citalopram—alcohol dependence	3.59e-05	0.000367	CcSEcCtD
Paroxetine—Mental disorder—Citalopram—alcohol dependence	3.56e-05	0.000363	CcSEcCtD
Paroxetine—Hypersensitivity—Acamprosate—alcohol dependence	3.55e-05	0.000362	CcSEcCtD
Paroxetine—Malnutrition—Citalopram—alcohol dependence	3.54e-05	0.000361	CcSEcCtD
Paroxetine—Erythema—Citalopram—alcohol dependence	3.54e-05	0.000361	CcSEcCtD
Paroxetine—Flatulence—Citalopram—alcohol dependence	3.48e-05	0.000356	CcSEcCtD
Paroxetine—Tension—Citalopram—alcohol dependence	3.47e-05	0.000354	CcSEcCtD
Paroxetine—Dysgeusia—Citalopram—alcohol dependence	3.46e-05	0.000354	CcSEcCtD
Paroxetine—Asthenia—Acamprosate—alcohol dependence	3.45e-05	0.000353	CcSEcCtD
Paroxetine—Nervousness—Citalopram—alcohol dependence	3.43e-05	0.000351	CcSEcCtD
Paroxetine—Back pain—Citalopram—alcohol dependence	3.42e-05	0.000349	CcSEcCtD
Paroxetine—Pruritus—Acamprosate—alcohol dependence	3.41e-05	0.000348	CcSEcCtD
Paroxetine—Muscle spasms—Citalopram—alcohol dependence	3.4e-05	0.000347	CcSEcCtD
Paroxetine—Hypersensitivity—Naltrexone—alcohol dependence	3.35e-05	0.000343	CcSEcCtD
Paroxetine—Vision blurred—Citalopram—alcohol dependence	3.33e-05	0.00034	CcSEcCtD
Paroxetine—Tremor—Citalopram—alcohol dependence	3.31e-05	0.000338	CcSEcCtD
Paroxetine—Diarrhoea—Acamprosate—alcohol dependence	3.29e-05	0.000336	CcSEcCtD
Paroxetine—Ill-defined disorder—Citalopram—alcohol dependence	3.28e-05	0.000335	CcSEcCtD
Paroxetine—Anaemia—Citalopram—alcohol dependence	3.27e-05	0.000334	CcSEcCtD
Paroxetine—Asthenia—Naltrexone—alcohol dependence	3.27e-05	0.000334	CcSEcCtD
Paroxetine—Agitation—Citalopram—alcohol dependence	3.25e-05	0.000332	CcSEcCtD
Paroxetine—Angioedema—Citalopram—alcohol dependence	3.23e-05	0.00033	CcSEcCtD
Paroxetine—Pruritus—Naltrexone—alcohol dependence	3.22e-05	0.000329	CcSEcCtD
Paroxetine—Malaise—Citalopram—alcohol dependence	3.19e-05	0.000326	CcSEcCtD
Paroxetine—Dizziness—Acamprosate—alcohol dependence	3.18e-05	0.000325	CcSEcCtD
Paroxetine—Vertigo—Citalopram—alcohol dependence	3.18e-05	0.000324	CcSEcCtD
Paroxetine—Syncope—Citalopram—alcohol dependence	3.17e-05	0.000324	CcSEcCtD
Paroxetine—Leukopenia—Citalopram—alcohol dependence	3.16e-05	0.000323	CcSEcCtD
Paroxetine—Palpitations—Citalopram—alcohol dependence	3.12e-05	0.000319	CcSEcCtD
Paroxetine—Diarrhoea—Naltrexone—alcohol dependence	3.12e-05	0.000318	CcSEcCtD
Paroxetine—Loss of consciousness—Citalopram—alcohol dependence	3.11e-05	0.000317	CcSEcCtD
Paroxetine—Cough—Citalopram—alcohol dependence	3.08e-05	0.000315	CcSEcCtD
Paroxetine—Convulsion—Citalopram—alcohol dependence	3.06e-05	0.000313	CcSEcCtD
Paroxetine—Vomiting—Acamprosate—alcohol dependence	3.06e-05	0.000313	CcSEcCtD
Paroxetine—Hypertension—Citalopram—alcohol dependence	3.05e-05	0.000312	CcSEcCtD
Paroxetine—Rash—Acamprosate—alcohol dependence	3.03e-05	0.00031	CcSEcCtD
Paroxetine—Dermatitis—Acamprosate—alcohol dependence	3.03e-05	0.00031	CcSEcCtD
Paroxetine—Headache—Acamprosate—alcohol dependence	3.02e-05	0.000308	CcSEcCtD
Paroxetine—Dizziness—Naltrexone—alcohol dependence	3.01e-05	0.000308	CcSEcCtD
Paroxetine—Myalgia—Citalopram—alcohol dependence	3.01e-05	0.000307	CcSEcCtD
Paroxetine—Chest pain—Citalopram—alcohol dependence	3.01e-05	0.000307	CcSEcCtD
Paroxetine—Arthralgia—Citalopram—alcohol dependence	3.01e-05	0.000307	CcSEcCtD
Paroxetine—Anxiety—Citalopram—alcohol dependence	3e-05	0.000306	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	2.99e-05	0.000305	CcSEcCtD
Paroxetine—Discomfort—Citalopram—alcohol dependence	2.97e-05	0.000304	CcSEcCtD
Paroxetine—Dry mouth—Citalopram—alcohol dependence	2.94e-05	0.000301	CcSEcCtD
Paroxetine—Confusional state—Citalopram—alcohol dependence	2.91e-05	0.000297	CcSEcCtD
Paroxetine—Vomiting—Naltrexone—alcohol dependence	2.9e-05	0.000296	CcSEcCtD
Paroxetine—Oedema—Citalopram—alcohol dependence	2.89e-05	0.000295	CcSEcCtD
Paroxetine—Anaphylactic shock—Citalopram—alcohol dependence	2.89e-05	0.000295	CcSEcCtD
Paroxetine—Rash—Naltrexone—alcohol dependence	2.87e-05	0.000293	CcSEcCtD
Paroxetine—Dermatitis—Naltrexone—alcohol dependence	2.87e-05	0.000293	CcSEcCtD
Paroxetine—Infection—Citalopram—alcohol dependence	2.87e-05	0.000293	CcSEcCtD
Paroxetine—Nausea—Acamprosate—alcohol dependence	2.86e-05	0.000292	CcSEcCtD
Paroxetine—Headache—Naltrexone—alcohol dependence	2.85e-05	0.000291	CcSEcCtD
Paroxetine—Shock—Citalopram—alcohol dependence	2.84e-05	0.00029	CcSEcCtD
Paroxetine—Nervous system disorder—Citalopram—alcohol dependence	2.83e-05	0.000289	CcSEcCtD
Paroxetine—Thrombocytopenia—Citalopram—alcohol dependence	2.82e-05	0.000289	CcSEcCtD
Paroxetine—Tachycardia—Citalopram—alcohol dependence	2.82e-05	0.000288	CcSEcCtD
Paroxetine—Skin disorder—Citalopram—alcohol dependence	2.8e-05	0.000286	CcSEcCtD
Paroxetine—Hyperhidrosis—Citalopram—alcohol dependence	2.79e-05	0.000285	CcSEcCtD
Paroxetine—Nausea—Naltrexone—alcohol dependence	2.7e-05	0.000276	CcSEcCtD
Paroxetine—Hypotension—Citalopram—alcohol dependence	2.7e-05	0.000275	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Citalopram—alcohol dependence	2.63e-05	0.000269	CcSEcCtD
Paroxetine—Insomnia—Citalopram—alcohol dependence	2.61e-05	0.000267	CcSEcCtD
Paroxetine—Paraesthesia—Citalopram—alcohol dependence	2.59e-05	0.000265	CcSEcCtD
Paroxetine—Dyspnoea—Citalopram—alcohol dependence	2.57e-05	0.000263	CcSEcCtD
Paroxetine—Somnolence—Citalopram—alcohol dependence	2.57e-05	0.000262	CcSEcCtD
Paroxetine—Dyspepsia—Citalopram—alcohol dependence	2.54e-05	0.000259	CcSEcCtD
Paroxetine—Decreased appetite—Citalopram—alcohol dependence	2.51e-05	0.000256	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Citalopram—alcohol dependence	2.49e-05	0.000254	CcSEcCtD
Paroxetine—Fatigue—Citalopram—alcohol dependence	2.49e-05	0.000254	CcSEcCtD
Paroxetine—Pain—Citalopram—alcohol dependence	2.47e-05	0.000252	CcSEcCtD
Paroxetine—Constipation—Citalopram—alcohol dependence	2.47e-05	0.000252	CcSEcCtD
Paroxetine—Feeling abnormal—Citalopram—alcohol dependence	2.38e-05	0.000243	CcSEcCtD
Paroxetine—Gastrointestinal pain—Citalopram—alcohol dependence	2.36e-05	0.000241	CcSEcCtD
Paroxetine—Urticaria—Citalopram—alcohol dependence	2.29e-05	0.000234	CcSEcCtD
Paroxetine—Abdominal pain—Citalopram—alcohol dependence	2.28e-05	0.000233	CcSEcCtD
Paroxetine—Body temperature increased—Citalopram—alcohol dependence	2.28e-05	0.000233	CcSEcCtD
Paroxetine—Hypersensitivity—Citalopram—alcohol dependence	2.13e-05	0.000217	CcSEcCtD
Paroxetine—Asthenia—Citalopram—alcohol dependence	2.07e-05	0.000211	CcSEcCtD
Paroxetine—Pruritus—Citalopram—alcohol dependence	2.04e-05	0.000209	CcSEcCtD
Paroxetine—Diarrhoea—Citalopram—alcohol dependence	1.97e-05	0.000202	CcSEcCtD
Paroxetine—Dizziness—Citalopram—alcohol dependence	1.91e-05	0.000195	CcSEcCtD
Paroxetine—Vomiting—Citalopram—alcohol dependence	1.83e-05	0.000187	CcSEcCtD
Paroxetine—Rash—Citalopram—alcohol dependence	1.82e-05	0.000186	CcSEcCtD
Paroxetine—Dermatitis—Citalopram—alcohol dependence	1.82e-05	0.000186	CcSEcCtD
Paroxetine—Headache—Citalopram—alcohol dependence	1.81e-05	0.000185	CcSEcCtD
Paroxetine—Nausea—Citalopram—alcohol dependence	1.71e-05	0.000175	CcSEcCtD
Paroxetine—CHRM1—Signaling by GPCR—HTR1B—alcohol dependence	8.75e-06	0.000183	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—CRH—alcohol dependence	8.75e-06	0.000183	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—GGT2—alcohol dependence	8.75e-06	0.000183	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—CRH—alcohol dependence	8.72e-06	0.000182	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—HTR1B—alcohol dependence	8.72e-06	0.000182	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—ADH1A—alcohol dependence	8.7e-06	0.000182	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—HTR1B—alcohol dependence	8.64e-06	0.00018	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—CRH—alcohol dependence	8.64e-06	0.00018	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—OPRM1—alcohol dependence	8.63e-06	0.00018	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—AVP—alcohol dependence	8.52e-06	0.000178	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—DRD4—alcohol dependence	8.47e-06	0.000177	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—DRD4—alcohol dependence	8.42e-06	0.000176	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—DRD4—alcohol dependence	8.39e-06	0.000175	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—DRD4—alcohol dependence	8.31e-06	0.000174	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—OPRM1—alcohol dependence	8.27e-06	0.000173	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—HTR2A—alcohol dependence	8.15e-06	0.00017	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—CNR1—alcohol dependence	8.08e-06	0.000169	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—CNR1—alcohol dependence	8.04e-06	0.000168	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—CNR1—alcohol dependence	8.01e-06	0.000167	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—ADH1B—alcohol dependence	8e-06	0.000167	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—NPY—alcohol dependence	7.94e-06	0.000166	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—CNR1—alcohol dependence	7.94e-06	0.000166	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—ADH4—alcohol dependence	7.92e-06	0.000165	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—DRD2—alcohol dependence	7.89e-06	0.000165	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—HTR7—alcohol dependence	7.89e-06	0.000165	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	7.87e-06	0.000164	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—HTR7—alcohol dependence	7.84e-06	0.000164	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—DRD2—alcohol dependence	7.84e-06	0.000164	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—DRD2—alcohol dependence	7.82e-06	0.000163	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—HTR7—alcohol dependence	7.82e-06	0.000163	CbGpPWpGaD
Paroxetine—HTR2A—GPCR ligand binding—POMC—alcohol dependence	7.81e-06	0.000163	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—HTR2A—alcohol dependence	7.8e-06	0.000163	CbGpPWpGaD
Paroxetine—CHRM1—GPCR ligand binding—POMC—alcohol dependence	7.76e-06	0.000162	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—HTR7—alcohol dependence	7.74e-06	0.000162	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—DRD2—alcohol dependence	7.74e-06	0.000162	CbGpPWpGaD
Paroxetine—CHRM3—GPCR ligand binding—POMC—alcohol dependence	7.74e-06	0.000162	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—ADH7—alcohol dependence	7.72e-06	0.000161	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—MAOB—alcohol dependence	7.71e-06	0.000161	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—DRD4—alcohol dependence	7.69e-06	0.000161	CbGpPWpGaD
Paroxetine—CHRM2—GPCR ligand binding—POMC—alcohol dependence	7.66e-06	0.00016	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CRH—alcohol dependence	7.66e-06	0.00016	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—HTR1B—alcohol dependence	7.66e-06	0.00016	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—DRD4—alcohol dependence	7.65e-06	0.00016	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—DRD4—alcohol dependence	7.62e-06	0.000159	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—NPY—alcohol dependence	7.61e-06	0.000159	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—OPRD1—alcohol dependence	7.61e-06	0.000159	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—POMC—alcohol dependence	7.6e-06	0.000159	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—OPRD1—alcohol dependence	7.57e-06	0.000158	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—DRD4—alcohol dependence	7.55e-06	0.000158	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—OPRD1—alcohol dependence	7.54e-06	0.000158	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—OPRD1—alcohol dependence	7.47e-06	0.000156	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—ADH4—alcohol dependence	7.46e-06	0.000156	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—GGT2—alcohol dependence	7.41e-06	0.000155	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—HTR2A—alcohol dependence	7.4e-06	0.000155	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—ADH4—alcohol dependence	7.39e-06	0.000154	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—CNR1—alcohol dependence	7.34e-06	0.000153	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CRH—alcohol dependence	7.34e-06	0.000153	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—HTR1B—alcohol dependence	7.34e-06	0.000153	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—CNR1—alcohol dependence	7.3e-06	0.000153	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—PDYN—alcohol dependence	7.29e-06	0.000152	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—CNR1—alcohol dependence	7.28e-06	0.000152	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—PDYN—alcohol dependence	7.25e-06	0.000152	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—PDYN—alcohol dependence	7.23e-06	0.000151	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—CNR1—alcohol dependence	7.21e-06	0.000151	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—HTR7—alcohol dependence	7.16e-06	0.00015	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—DRD2—alcohol dependence	7.16e-06	0.00015	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—PDYN—alcohol dependence	7.16e-06	0.00015	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—HTR7—alcohol dependence	7.12e-06	0.000149	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—DRD2—alcohol dependence	7.12e-06	0.000149	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—HTR7—alcohol dependence	7.1e-06	0.000148	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—DRD2—alcohol dependence	7.1e-06	0.000148	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—HTR2A—alcohol dependence	7.09e-06	0.000148	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—HTR7—alcohol dependence	7.03e-06	0.000147	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—DRD2—alcohol dependence	7.03e-06	0.000147	CbGpPWpGaD
Paroxetine—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	6.92e-06	0.000144	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—WASF2—alcohol dependence	6.78e-06	0.000142	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CRHR1—alcohol dependence	6.78e-06	0.000142	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—ADH1B—alcohol dependence	6.77e-06	0.000141	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—WASF2—alcohol dependence	6.74e-06	0.000141	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CRHR1—alcohol dependence	6.74e-06	0.000141	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—ADH7—alcohol dependence	6.73e-06	0.000141	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CRHR1—alcohol dependence	6.72e-06	0.00014	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—WASF2—alcohol dependence	6.72e-06	0.00014	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—DRD4—alcohol dependence	6.7e-06	0.00014	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—WASF2—alcohol dependence	6.66e-06	0.000139	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CRHR1—alcohol dependence	6.66e-06	0.000139	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—AVP—alcohol dependence	6.64e-06	0.000139	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—MAOB—alcohol dependence	6.63e-06	0.000138	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—AVP—alcohol dependence	6.6e-06	0.000138	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—AVP—alcohol dependence	6.58e-06	0.000137	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—ALDH2—alcohol dependence	6.55e-06	0.000137	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—AVP—alcohol dependence	6.52e-06	0.000136	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—POMC—alcohol dependence	6.51e-06	0.000136	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—WASF1—alcohol dependence	6.5e-06	0.000136	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—WASF1—alcohol dependence	6.46e-06	0.000135	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—GGT2—alcohol dependence	6.45e-06	0.000135	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—WASF1—alcohol dependence	6.44e-06	0.000135	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—DRD4—alcohol dependence	6.42e-06	0.000134	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	6.4e-06	0.000134	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CNR1—alcohol dependence	6.4e-06	0.000134	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—WASF1—alcohol dependence	6.38e-06	0.000133	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CHRM2—alcohol dependence	6.37e-06	0.000133	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	6.35e-06	0.000133	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—ADH7—alcohol dependence	6.34e-06	0.000132	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CHRM2—alcohol dependence	6.34e-06	0.000132	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CHRM2—alcohol dependence	6.32e-06	0.000132	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—ADH7—alcohol dependence	6.29e-06	0.000131	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—HTR7—alcohol dependence	6.24e-06	0.00013	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—DRD2—alcohol dependence	6.24e-06	0.00013	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—POMC—alcohol dependence	6.23e-06	0.00013	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CNR1—alcohol dependence	6.13e-06	0.000128	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—GGT2—alcohol dependence	6.08e-06	0.000127	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—AVP—alcohol dependence	6.03e-06	0.000126	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—GGT2—alcohol dependence	6.03e-06	0.000126	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—AVP—alcohol dependence	6e-06	0.000125	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—AVP—alcohol dependence	5.98e-06	0.000125	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—HTR7—alcohol dependence	5.98e-06	0.000125	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—DRD2—alcohol dependence	5.98e-06	0.000125	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—AVP—alcohol dependence	5.92e-06	0.000124	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—POMC—alcohol dependence	5.91e-06	0.000123	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—ADH1B—alcohol dependence	5.9e-06	0.000123	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—OPRM1—alcohol dependence	5.85e-06	0.000122	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—OPRM1—alcohol dependence	5.82e-06	0.000122	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—OPRM1—alcohol dependence	5.8e-06	0.000121	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—OPRM1—alcohol dependence	5.75e-06	0.00012	CbGpPWpGaD
Paroxetine—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	5.72e-06	0.000119	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—POMC—alcohol dependence	5.66e-06	0.000118	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—ALDH2—alcohol dependence	5.64e-06	0.000118	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—MAOB—alcohol dependence	5.61e-06	0.000117	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—GOT2—alcohol dependence	5.57e-06	0.000116	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—ADH1B—alcohol dependence	5.56e-06	0.000116	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—ADH1B—alcohol dependence	5.51e-06	0.000115	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—HTR2A—alcohol dependence	5.49e-06	0.000115	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—HTR2A—alcohol dependence	5.48e-06	0.000114	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—HTR2A—alcohol dependence	5.42e-06	0.000113	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—NPY—alcohol dependence	5.39e-06	0.000112	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—NPY—alcohol dependence	5.36e-06	0.000112	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—NPY—alcohol dependence	5.34e-06	0.000112	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—NPY—alcohol dependence	5.29e-06	0.00011	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—AVP—alcohol dependence	5.25e-06	0.00011	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—CYP2E1—alcohol dependence	5.24e-06	0.000109	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—HTR1B—alcohol dependence	5.2e-06	0.000109	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CRH—alcohol dependence	5.2e-06	0.000109	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—HTR1B—alcohol dependence	5.17e-06	0.000108	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CRH—alcohol dependence	5.17e-06	0.000108	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—HTR1B—alcohol dependence	5.15e-06	0.000108	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CRH—alcohol dependence	5.15e-06	0.000108	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—HTR1B—alcohol dependence	5.1e-06	0.000107	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CRH—alcohol dependence	5.1e-06	0.000107	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—EP300—alcohol dependence	5.04e-06	0.000105	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—AVP—alcohol dependence	5.03e-06	0.000105	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—HTR2A—alcohol dependence	4.99e-06	0.000104	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—HTR2A—alcohol dependence	4.97e-06	0.000104	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—HTR2A—alcohol dependence	4.93e-06	0.000103	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—MAOB—alcohol dependence	4.89e-06	0.000102	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—GGT1—alcohol dependence	4.81e-06	0.0001	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—GOT1—alcohol dependence	4.81e-06	0.0001	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—GOT2—alcohol dependence	4.79e-06	0.0001	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—ALDH2—alcohol dependence	4.77e-06	9.97e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—MAOB—alcohol dependence	4.61e-06	9.63e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	4.59e-06	9.59e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—MAOB—alcohol dependence	4.57e-06	9.54e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—DRD4—alcohol dependence	4.54e-06	9.49e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—DRD4—alcohol dependence	4.52e-06	9.44e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—CYP2E1—alcohol dependence	4.51e-06	9.41e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—DRD4—alcohol dependence	4.5e-06	9.41e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—DRD4—alcohol dependence	4.46e-06	9.31e-05	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—POMC—alcohol dependence	4.41e-06	9.21e-05	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—POMC—alcohol dependence	4.39e-06	9.17e-05	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—POMC—alcohol dependence	4.37e-06	9.14e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—HTR2A—alcohol dependence	4.37e-06	9.13e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CNR1—alcohol dependence	4.34e-06	9.06e-05	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—POMC—alcohol dependence	4.33e-06	9.05e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CNR1—alcohol dependence	4.31e-06	9.01e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—MAOA—alcohol dependence	4.31e-06	9e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CNR1—alcohol dependence	4.3e-06	8.98e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CNR1—alcohol dependence	4.26e-06	8.89e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—HTR7—alcohol dependence	4.23e-06	8.84e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—DRD2—alcohol dependence	4.23e-06	8.84e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—DRD2—alcohol dependence	4.21e-06	8.79e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—HTR7—alcohol dependence	4.21e-06	8.79e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—DRD2—alcohol dependence	4.19e-06	8.76e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—HTR7—alcohol dependence	4.19e-06	8.76e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—HTR2A—alcohol dependence	4.19e-06	8.74e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—ALDH2—alcohol dependence	4.16e-06	8.69e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—HTR7—alcohol dependence	4.15e-06	8.68e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—DRD2—alcohol dependence	4.15e-06	8.68e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—GOT1—alcohol dependence	4.14e-06	8.64e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—GGT1—alcohol dependence	4.14e-06	8.64e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—GOT2—alcohol dependence	4.06e-06	8.48e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—POMC—alcohol dependence	4.01e-06	8.37e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—POMC—alcohol dependence	3.98e-06	8.32e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—POMC—alcohol dependence	3.97e-06	8.3e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—POMC—alcohol dependence	3.93e-06	8.22e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—ALDH2—alcohol dependence	3.92e-06	8.18e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—ALDH2—alcohol dependence	3.88e-06	8.11e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—CYP2E1—alcohol dependence	3.82e-06	7.97e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	3.73e-06	7.8e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—MAOA—alcohol dependence	3.71e-06	7.75e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—AVP—alcohol dependence	3.56e-06	7.44e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—AVP—alcohol dependence	3.54e-06	7.4e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—GOT2—alcohol dependence	3.54e-06	7.38e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—AVP—alcohol dependence	3.53e-06	7.38e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—GOT1—alcohol dependence	3.5e-06	7.32e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—GGT1—alcohol dependence	3.5e-06	7.32e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—AVP—alcohol dependence	3.5e-06	7.3e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—POMC—alcohol dependence	3.49e-06	7.29e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—POMC—alcohol dependence	3.34e-06	6.98e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—GOT2—alcohol dependence	3.33e-06	6.96e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—CYP2E1—alcohol dependence	3.32e-06	6.94e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—GOT2—alcohol dependence	3.3e-06	6.9e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—MAOA—alcohol dependence	3.14e-06	6.56e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—CYP2E1—alcohol dependence	3.13e-06	6.54e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—CYP2E1—alcohol dependence	3.11e-06	6.49e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—GGT1—alcohol dependence	3.05e-06	6.37e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—GOT1—alcohol dependence	3.05e-06	6.37e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	3.04e-06	6.36e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—HTR2A—alcohol dependence	2.95e-06	6.16e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—HTR2A—alcohol dependence	2.94e-06	6.14e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—HTR2A—alcohol dependence	2.91e-06	6.08e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—GGT1—alcohol dependence	2.88e-06	6.01e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—GOT1—alcohol dependence	2.88e-06	6.01e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—GGT1—alcohol dependence	2.85e-06	5.96e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—GOT1—alcohol dependence	2.85e-06	5.96e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—POMC—alcohol dependence	2.81e-06	5.86e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—MAOA—alcohol dependence	2.73e-06	5.71e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—MAOA—alcohol dependence	2.58e-06	5.38e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—MAOA—alcohol dependence	2.55e-06	5.34e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.48e-06	5.18e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—POMC—alcohol dependence	2.41e-06	5.04e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—POMC—alcohol dependence	2.37e-06	4.94e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—POMC—alcohol dependence	2.35e-06	4.92e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—POMC—alcohol dependence	2.35e-06	4.9e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—POMC—alcohol dependence	2.32e-06	4.85e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—EP300—alcohol dependence	2.32e-06	4.84e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—EP300—alcohol dependence	2.22e-06	4.63e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—POMC—alcohol dependence	2.04e-06	4.27e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—EP300—alcohol dependence	1.86e-06	3.89e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—POMC—alcohol dependence	1.78e-06	3.72e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—POMC—alcohol dependence	1.68e-06	3.5e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—POMC—alcohol dependence	1.66e-06	3.47e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—EP300—alcohol dependence	1.6e-06	3.35e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—EP300—alcohol dependence	1.57e-06	3.28e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—EP300—alcohol dependence	1.56e-06	3.26e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—EP300—alcohol dependence	1.56e-06	3.25e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—EP300—alcohol dependence	1.54e-06	3.22e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—EP300—alcohol dependence	1.36e-06	2.83e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—EP300—alcohol dependence	1.18e-06	2.47e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—EP300—alcohol dependence	1.11e-06	2.32e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—EP300—alcohol dependence	1.1e-06	2.3e-05	CbGpPWpGaD
